Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Immunoglobulin E as a promising new form of anti-cancer immunotherapy

05.06.2018

If immunoglobulin E (IgE) antibodies are directed against harmless antigens such as pollen, the result can be an allergic reaction. However the original purpose of these IgE antibodies is to repel harmful exogenous substances rather than to trigger allergies. In collaboration with Vetmeduni Vienna and international scientists, researchers from MedUni Vienna have now made use this function: they have developed a "canine IgE" that directly targets the EGFR growth factor in cancerous tumours. The main finding: in-vitro studies showed that the tumour was destroyed by the IgE antibodies in more than 60% of cases.

The response of endogenous immunoglobulin E that leads to the development of allergies is "pointless", because it interacts with inflammatory cells to turn against harmless antigens , thereby causing serious allergies.


A new immunoglobulin E specialised for dogs may be an effective support in cancer therapy.

Michael Bernkopf/Vetmeduni Vienna

"Our motto in the current study is: Is there any point to IgE?" says its lead author, Erika Jensen-Jarolim, who has dual affiliation, both to MedUni Vienna's Institute of Pathophysiology and Allergy Research and to the inter-university Messerli Research Institute of the University of Veterinary Medicine Vienna, Medical University of Vienna and University of Vienna.

"Using dogs as ' model patients’, we were able to show that tumours that have the EGFR growth factor can be killed by immunoglobulin E, irrespective of the breed of dog," explains Jensen-Jarolim. By the way, the 3rd of June is "Day of the Dog".

The results of the study, which have now been published in leading magazine "Journal of Allergy and Clinical Immunology" (JACI), are also highly promising, since canine EGFR is a 92% match for human EGFR. IgE antibodies build a "bridge", as it were, between the EGFR on cancer cells and the inflammatory cells, thereby releasing tumour necrosis factors – which immediately start to kill the tumours.

Says Jensen-Jarolim: "We can therefore hope that we have made an important contribution towards developing a new form of immunotherapy against cancerous tumours. A subsequent clinical trial will be conducted in canine patients to validate the results in an international joint initiative before moving to human trials. "This paper is a perfect example of what we are all about at the Messerli Research Institute: improving medicine for people but for animals as well."

Service:
"AllergoOncology: Generating a canine anti-cancer IGE against the epidermal growth factor receptor (EGFR)". J. Fazakas-Singer, J. Singer, K. Ilieva, M. Matz, I. Herrmann, E. Spillner, S. Karagiannis, E. Jensen-Jarolim. Journal of Allergy and Clinical Immunology, June 2018. doi: 10.1016/j.jaci.2018.04.021. Link: https://www.ncbi.nlm.nih.gov/pubmed/29746883.

About the University of Veterinary Medicine, Vienna
The University of Veterinary Medicine, Vienna in Austria is one of the leading academic and research institutions in the field of Veterinary Sciences in Europe. About 1,300 employees and 2,300 students work on the campus in the north of Vienna which also houses five university clinics and various research sites. Outside of Vienna the university operates Teaching and Research Farms. The Vetmeduni Vienna plays in the global top league: in 2017, it occupies the excellent place 8 in the world-wide Shanghai University veterinary in the subject "Veterinary Science". http://www.vetmeduni.ac.at

Scientific Contact:
Erika Jensen-Jarolim
Comparative Medicine, Messerli Research Institute
University of Veterinary Medicine Vienna (Vetmeduni Vienna)
T +43 1 25077-2660
erika.jensen-jarolim@vetmeduni.ac.at

Released by:
Georg Mair
Science Communication / Corporate Communications
University of Veterinary Medicine Vienna (Vetmeduni Vienna)
T +43 1 25077-1165
georg.mair@vetmeduni.ac.at

Medical University Vienna - short profile
Medical University Vienna (MedUni Vienna) is one of the most traditional medical education and research facilities in Europe. With almost 8,000 students, it is currently the largest medical training centre in the German-speaking countries. With 5,500 employees, 26 departments and three clinical institutes, 12 medical theory centres and numerous highly specialised laboratories, it is also one of Europe's leading research establishments in the biomedical sector.

About Messerli Research Institute
The Messerli Research Institute was founded in 2010 with support from the Messerli Foundation (Sörenberg, Switzerland) under the management of the University of Veterinary Medicine, Vienna in cooperation with the Medical University of Vienna and the University of Vienna. The research is devoted to the interaction between humans and animals, as well as its theoretical principles in animal cognition and behavior, comparative medicine and ethics. Its work is characterized by its broad interdisciplinary approach (biology, human medicine, veterinary medicine, philosophy, psychology, law) and strong international focus. http://www.vetmeduni.ac.at/en/messerli/

Weitere Informationen:

http://www.vetmeduni.ac.at/en/infoservice/presseinformation/presse-releases-2018...

Mag.rer.nat. Georg Mair | idw - Informationsdienst Wissenschaft

More articles from Life Sciences:

nachricht New eDNA technology used to quickly assess coral reefs
18.04.2019 | University of Hawaii at Manoa

nachricht New automated biological-sample analysis systems to accelerate disease detection
18.04.2019 | Polytechnique Montréal

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Explosion on Jupiter-sized star 10 times more powerful than ever seen on our sun

A stellar flare 10 times more powerful than anything seen on our sun has burst from an ultracool star almost the same size as Jupiter

  • Coolest and smallest star to produce a superflare found
  • Star is a tenth of the radius of our Sun
  • Researchers led by University of Warwick could only see...

Im Focus: Quantum simulation more stable than expected

A localization phenomenon boosts the accuracy of solving quantum many-body problems with quantum computers which are otherwise challenging for conventional computers. This brings such digital quantum simulation within reach on quantum devices available today.

Quantum computers promise to solve certain computational problems exponentially faster than any classical machine. “A particularly promising application is the...

Im Focus: Largest, fastest array of microscopic 'traffic cops' for optical communications

The technology could revolutionize how information travels through data centers and artificial intelligence networks

Engineers at the University of California, Berkeley have built a new photonic switch that can control the direction of light passing through optical fibers...

Im Focus: A long-distance relationship in femtoseconds

Physicists observe how electron-hole pairs drift apart at ultrafast speed, but still remain strongly bound.

Modern electronics relies on ultrafast charge motion on ever shorter length scales. Physicists from Regensburg and Gothenburg have now succeeded in resolving a...

Im Focus: Researchers 3D print metamaterials with novel optical properties

Engineers create novel optical devices, including a moth eye-inspired omnidirectional microwave antenna

A team of engineers at Tufts University has developed a series of 3D printed metamaterials with unique microwave or optical properties that go beyond what is...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Revered mathematicians and computer scientists converge with 200 young researchers in Heidelberg!

17.04.2019 | Event News

First dust conference in the Central Asian part of the earth’s dust belt

15.04.2019 | Event News

Fraunhofer FHR at the IEEE Radar Conference 2019 in Boston, USA

09.04.2019 | Event News

 
Latest News

New automated biological-sample analysis systems to accelerate disease detection

18.04.2019 | Life Sciences

Explosion on Jupiter-sized star 10 times more powerful than ever seen on our sun

18.04.2019 | Physics and Astronomy

New eDNA technology used to quickly assess coral reefs

18.04.2019 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>